Collin C et al. |
Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479747
|
Hampson AJ et al. |
Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor. |
1995 |
Biochim. Biophys. Acta |
pmid:7488638
|
Schmid PC et al. |
Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. |
1995 |
FEBS Lett. |
pmid:7498458
|
Hansen HS et al. |
Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture. |
1995 |
Biochim. Biophys. Acta |
pmid:7548201
|
Ueda N et al. |
Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. |
1995 |
J. Biol. Chem. |
pmid:7559559
|
Felder CC et al. |
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. |
1995 |
Mol. Pharmacol. |
pmid:7565624
|
Vela G et al. |
Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. |
1995 |
Neuropharmacology |
pmid:7566503
|
Paria BC et al. |
The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7568154
|
Sugiura T et al. |
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. |
1995 |
Biochem. Biophys. Res. Commun. |
pmid:7575630
|
Guzmán M et al. |
Effects of anandamide on hepatic fatty acid metabolism. |
1995 |
Biochem. Pharmacol. |
pmid:7575652
|
Varga K et al. |
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. |
1995 |
Eur. J. Pharmacol. |
pmid:7589169
|
Ueda N |
[Anandamide: an endogenous cannabinoid receptor agonist]. |
1995 |
Seikagaku |
pmid:7594870
|
Mechoulam R et al. |
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. |
1995 |
Biochem. Pharmacol. |
pmid:7605349
|
Venance L et al. |
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. |
1995 |
Nature |
pmid:7637807
|
Hillard CJ et al. |
Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. |
1995 |
Biochim. Biophys. Acta |
pmid:7647100
|
Priller J et al. |
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. |
1995 |
Mol. Pharmacol. |
pmid:7651362
|
Bornheim LM et al. |
Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. |
1995 |
Biochem. Pharmacol. |
pmid:7669071
|
Di Marzo V and Fontana A |
Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'. |
1995 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:7675818
|
Romero J et al. |
Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. |
1995 |
Pharmacol. Biochem. Behav. |
pmid:7675852
|
Munro S et al. |
Molecular characterization of a peripheral receptor for cannabinoids. |
1993 |
Nature |
pmid:7689702
|